See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Half Sinemet CR, Sinemet CR, Sinemet Plus, Syndopa CR
Generic Name: Carbidopa-Levodopa CR
What is Carbidopa-Levodopa CR? A controlled release preparation of carbidopa/levodopa formulated to release a lower, smoother dose of medication. It is sometimes taken last thing at night in order to maintain dopamine levels throughout sleep and into the morning.
See more information, including instructions, precautions, side effects, and interactions.
187 patients in the community are taking or have taken Carbidopa-Levodopa CR.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 145 | 82% |
| Stiffness/spasticity | 14 | 8% |
| Other | 7 | 4% |
| Slowness | 4 | 2% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Dry mouth (xerostomia) | 1 | <1% |
| disease-related symptoms | 1 | <1% |
| Mobility | 1 | <1% |
| Memory problems | 1 | <1% |
Based on the patients currently taking Carbidopa-Levodopa CR.
Top 10 (Show all)
All (Show Top 10)
| 0 mg day | 0 mg none | 0.75 mg day | 1 mg day | 50 mg month | 3 mg day | 3 day | 4 mg day | 4.5 mg day | 5 mg day | 6 mg day | 6 other day | 10 mg day | 12 mg day | 25 mg day | 30 mg day | 50 mg day | 75 mg day | 80 mg day | 100 mg day | 111 mg day | 125 mg day | 135 mg day | 150 mg day | 200 mg day | 200 mg none | 225 mg day | 250 mg day | 300 mg day | 400 mg day | 450 mg day | 500 mg day | 600 mg day | 700 mg day | 800 mg day | 1000 mg day | 1200 mg day | 1250 mg day | 1375 mg day | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
15
|
3
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
13
|
1
|
12
|
9
|
1
|
10
|
1
|
3
|
1
|
9
|
19
|
1
|
3
|
2
|
7
|
7
|
1
|
2
|
9
|
2
|
7
|
5
|
3
|
1
|
1
|
||
How long current patients have been taking Carbidopa-Levodopa CR or how long patients were taking Carbidopa-Levodopa CR before stopping.
Results from 7 patient evaluations. See the overall results and all individual evaluations.
| Major | 71% | 5 |
|---|---|---|
| Moderate | 14% | 1 |
| None | 14% | 1 |
Treat Parkinson's
| Severe | 14% | 1 |
|---|---|---|
| Moderate | 29% | 2 |
| Mild | 0% | 0 |
| None | 57% | 4 |
Top reported side-effects include: Fatigue, Back pain, Vivid dreams
Summary results are based on 7 individual responses. For more information, see overall results for Adherence, Burden and Cost.